Literature DB >> 16738954

Interleukin-12 to interleukin 'infinity': the rationale for future therapeutic cytokine targeting.

E J R Anderson1, M A McGrath, T Thalhamer, I B McInnes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16738954     DOI： 10.1007/s00281-006-0011-x

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  108 in total

1.  A role for IL-18 in neutrophil activation.

Authors:  B P Leung; S Culshaw; J A Gracie; D Hunter; C A Canetti; C Campbell; F Cunha; F Y Liew; I B McInnes
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

Review 2.  The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses.

Authors:  Giorgio Trinchieri; Stefan Pflanz; Robert A Kastelein
Journal:  Immunity       Date:  2003-11       Impact factor: 31.745

Review 3.  Interleukin-2 and interleukin-15: immunotherapy for cancer.

Authors:  Todd A Fehniger; Megan A Cooper; Michael A Caligiuri
Journal:  Cytokine Growth Factor Rev       Date:  2002-04       Impact factor: 7.638

4.  High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism.

Authors:  M Ziolkowska; A Koc; G Luszczykiewicz; K Ksiezopolska-Pietrzak; E Klimczak; H Chwalinska-Sadowska; W Maslinski
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

5.  Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme.

Authors:  Y Gu; K Kuida; H Tsutsui; G Ku; K Hsiao; M A Fleming; N Hayashi; K Higashino; H Okamura; K Nakanishi; M Kurimoto; T Tanimoto; R A Flavell; V Sato; M W Harding; D J Livingston; M S Su
Journal:  Science       Date:  1997-01-10       Impact factor: 47.728

6.  IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells.

Authors:  Stefan Pflanz; Jackie C Timans; Jeanne Cheung; Rency Rosales; Holger Kanzler; Jonathan Gilbert; Linda Hibbert; Tatyana Churakova; Marilyn Travis; Elena Vaisberg; Wendy M Blumenschein; Jeanine D Mattson; Janet L Wagner; Wayne To; Sandra Zurawski; Terrill K McClanahan; Daniel M Gorman; J Fernando Bazan; Rene de Waal Malefyt; Donna Rennick; Robert A Kastelein
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

7.  Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein.

Authors:  Nirmal K Banda; Andrea Vondracek; Damian Kraus; Charles A Dinarello; Soo-Hyun Kim; Alison Bendele; Giorgio Senaldi; William P Arend
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

8.  Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development.

Authors:  S Stoll; H Jonuleit; E Schmitt; G Müller; H Yamauchi; M Kurimoto; J Knop; A H Enk
Journal:  Eur J Immunol       Date:  1998-10       Impact factor: 5.532

9.  Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells.

Authors:  G Monteleone; L Biancone; R Marasco; G Morrone; O Marasco; F Luzza; F Pallone
Journal:  Gastroenterology       Date:  1997-04       Impact factor: 22.682

Review 10.  Interleukin-12 and the regulation of innate resistance and adaptive immunity.

Authors:  Giorgio Trinchieri
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106
View more
  3 in total

Review 1.  The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders.

Authors:  H E Barksby; S R Lea; P M Preshaw; J J Taylor
Journal:  Clin Exp Immunol       Date:  2007-06-21       Impact factor: 4.330

2.  Effects of alkylated-chitosan-DNA nanoparticles on the function of macrophages.

Authors:  L X Liu; C N Song; L P Song; H L Zhang; X Dong; X G Leng
Journal:  J Mater Sci Mater Med       Date:  2008-11-20       Impact factor: 3.896

3.  Sequential priming with simian immunodeficiency virus (SIV) DNA vaccines, with or without encoded cytokines, and a replicating adenovirus-SIV recombinant followed by protein boosting does not control a pathogenic SIVmac251 mucosal challenge.

Authors:  Thorsten Demberg; Jean D Boyer; Nina Malkevich; L Jean Patterson; David Venzon; Ebonita L Summers; Irene Kalisz; V S Kalyanaraman; Eun Mi Lee; David B Weiner; Marjorie Robert-Guroff
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.